feed,title,long_url,short_url
SeekingAlpha,Oxford Lane Capital estimates NAV/share of $4.86-$4.96,https://seekingalpha.com/news/3641343,
SeekingAlpha,Rezolute on go with early-stage study of oral DME candidate RZ402,https://seekingalpha.com/news/3641342,
SeekingAlpha,Beam Global up 9% premarket on patent issuance,https://seekingalpha.com/news/3641341,
SeekingAlpha,Palantir's Biggest Competition,https://seekingalpha.com/article/4392747,
SeekingAlpha,The New EU-U.K. Trading Relationship Could Deliver More U.K. Economic Pain,https://seekingalpha.com/article/4392751,
